Vester U, Offner G, Hoyer P F, Oldhafer K, Fangmann J, Pichlmayr R, Brodehl J
Kinderklinik der Medizinischen Hochschule Hannover, Germany.
Eur J Pediatr. 1998 Mar;157(3):239-42. doi: 10.1007/s004310050803.
Between 1975 and 1994, 46 children under 6 years of age received a total of 52 renal transplants. Obstructive uropathy and dysplasia accounted for most causes of terminal renal failure (17 and 12 cases respectively). Four patients required a second, 1 patient a third transplantation. Cadaveric organs were used on 33 occasions; 19 patients received a living-related donor kidney. Immunosuppression was performed with azathioprine in 5, with cyclosporine A in 21 and combined azathioprine/cyclosporine therapy in 20 cases. After 1 year, graft survival was 81%, and after 5 years 78%. Creatinine clearance declined slightly between 1 and 5 years from 69 to 56 ml/min per 1.73 m2. Main causes of graft failure were thrombotic complications in 6 cases and death with functioning graft in 5 cases. Graft thrombosis occurred only in grafts from young donors under the age of 7 years and after vascular anastomosis to the iliac vessels. Only two transplants were lost in rejection episodes. Patient survival was 94% after 1 and 90% after 5 years. Two patients died due to septiacemia, 1 died of a ruptured aortic aneurysm, 1 of cerebral ischaemia and 1 suddenly of unknown cause. Patient and graft survival was not different compared with 204 patients aged 6-16 years who received a renal transplantation during the same time period at our institution. After transplantation the patients receiving cyclosporine A showed a marked catch-up growth in the 1st year. The median standard deviation score (SDS) of body length improved from -2.63 to -1.39 standard deviations.
Renal transplantation is the treatment of choice in end-stage renal failure in children under 6 years.
1975年至1994年间,46名6岁以下儿童共接受了52次肾移植。梗阻性尿路病和发育异常是终末期肾衰竭的主要病因(分别为17例和12例)。4例患者需要进行第二次移植,1例患者需要进行第三次移植。33次使用了尸体器官;19例患者接受了亲属活体供肾。5例患者使用硫唑嘌呤进行免疫抑制,21例使用环孢素A,20例采用硫唑嘌呤/环孢素联合治疗。1年后,移植肾存活率为81%,5年后为78%。肌酐清除率在1至5年间略有下降,从每1.73平方米69毫升/分钟降至56毫升/分钟。移植肾失败的主要原因是血栓并发症6例,移植肾功能正常时患者死亡5例。移植肾血栓形成仅发生在7岁以下年轻供体的移植肾以及与髂血管进行血管吻合后。仅有两次移植因排斥反应而失败。1年后患者存活率为94%,5年后为90%。2例患者死于败血症,1例死于主动脉瘤破裂,1例死于脑缺血,1例原因不明突然死亡。与同期在我们机构接受肾移植的204名6至16岁患者相比,患者和移植肾存活率并无差异。移植后接受环孢素A治疗的患者在第1年出现明显的追赶生长。身长的中位标准差评分(SDS)从-2.63标准差提高到-1.39标准差。
肾移植是6岁以下儿童终末期肾衰竭的首选治疗方法。